Crash-Tested Stock Qualities
While the stock market has experienced a significant recovery from the March crash, “there are any number of ways stocks could be primed for another… Read More »Crash-Tested Stock Qualities
Stocks to Watch
2 Dividend Stock Shortlists For Conservative – And Moderately Conservative – Investors
From the more than 7,500 companies traded on US exchanges, a comprehensive filtering process leads to these two groups of five dividend stocks for income… Read More »2 Dividend Stock Shortlists For Conservative – And Moderately Conservative – Investors
The MOST Bang For Investors’ Bucks Over The Next 3 Months
MOST stocks have been consistent winners. That is, stocks that make it through Morgan Stanley’s Short Term (MOST) stock selection model, which seeks to identify… Read More »The MOST Bang For Investors’ Bucks Over The Next 3 Months
Get Bullish – And Consider These “Surprise To The Upside” Stocks
“What if you prepared for a bear market and no one came?” While bearish warnings continue to be issued, now may be the time to… Read More »Get Bullish – And Consider These “Surprise To The Upside” Stocks
Smaller Tech Companies, Bigger Upside?
While the biggest tech companies are dominating the market, Bank of America strategists believe that a select group of smaller tech firms may be poised… Read More »Smaller Tech Companies, Bigger Upside?
What Political Predictions Markets Can Teach Us About Making Money In The Stock Market
With less than six months to go until the 2020 election, political predictions markets are active – and understanding some of the key concepts in… Read More »What Political Predictions Markets Can Teach Us About Making Money In The Stock Market
This Healthcare-Technology Stock Checks All The Boxes For Massive Long-Term Returns
With a small current market cap, a huge total addressable market, and a game-changing platform, this healthcare-technology stock – which has already made some investors… Read More »This Healthcare-Technology Stock Checks All The Boxes For Massive Long-Term Returns
What About AbbVie?
Pharmaceutical giant AbbVie has weathered the COVID-19 storm relatively well, with its first-quarter revenue and earnings per share both coming in ahead of analyst estimates.… Read More »What About AbbVie?
The Pandemic Has Made Preferreds Even More Attractive
One positive effect of COVID-19? It has created a situation where high-quality preferred stocks – and their generous yields – are available at some of… Read More »The Pandemic Has Made Preferreds Even More Attractive
A Focus On Millennial Consumer Tendencies Is Helping This Fund Outperform Amid The Pandemic
The spreading COVID-19 pandemic and resulting lockdowns across Europe and the U.S. has forced the world to adopt millennial consumer tendencies and technologies – and… Read More »A Focus On Millennial Consumer Tendencies Is Helping This Fund Outperform Amid The Pandemic